Since the beginning of President Donald J. Trump’s second term, an unprecedented wave of private investment announcements has poured into American manufacturing, research, and innovation, totaling trillions of dollars across a wide range of industries and foreign partnerships. The surge, credited by supporters to Trump’s emphasis on domestic industrial resurgence, includes megaprojects in artificial intelligence, pharmaceuticals, data centers, energy infrastructure, and chip manufacturing.
The most prominent investment to date is Project Stargate, a $500 billion AI infrastructure initiative led by Japan-based SoftBank, OpenAI, and Oracle. NVIDIA followed suit with its own $500 billion pledge to manufacture AI supercomputers entirely in the U.S. Apple, IBM, and TSMC have each committed hundreds of billions toward domestic production and technological development.
Major pharmaceutical firms have also joined the investment trend. Johnson & Johnson announced a $55 billion initiative, Roche committed $50 billion, and Eli Lilly pledged $27 billion to expand U.S. manufacturing and R&D capabilities. These moves are expected to create tens of thousands of new jobs and reinforce domestic drug supply chains.
The logistics, energy, and automotive sectors have also seen significant commitments. UAE-based ADQ and DAMAC are jointly investing $45 billion in U.S. data and energy infrastructure. Hyundai revealed a $21 billion investment including a $5.8 billion steel plant in Louisiana, while Amazon committed $4 billion to small-town job creation across the country.
The sweeping influx of capital is being driven by both U.S.-based firms and foreign investors. “President Trump’s policies have revitalized American industry,” the announcement read, pointing to hundreds of billions in pledges from countries like Japan, Saudi Arabia, and the United Arab Emirates.
Broad global investment pledges expand U.S. industrial base
Beyond individual company announcements, nations are pledging sovereign-level capital to the United States. Japan has announced a $1 trillion commitment to U.S. investments, while the UAE plans to spend $1.4 trillion over the next decade. Saudi Arabia has pledged $600 billion in the next four years, with Taiwan also promising to ramp up its investments.
In manufacturing, a range of smaller firms are establishing or expanding U.S. operations. Clasen Quality Chocolate is building a $230 million facility in Virginia, Bel Group is investing $350 million across multiple states, and Guardian Bikes is launching a $19 million Indiana factory to build large-scale bike frames.
Several high-tech and defense-related facilities are also in development. Anduril Industries is constructing a $1 billion autonomous weapons system facility in Ohio. Regeneron and Fujifilm Diosynth Biotechnologies entered a $3 billion agreement for drug production in North Carolina. AeroVironment is spending over $40 million on a Utah facility for defense manufacturing.
Traditional sectors are not being left behind. Kimberly-Clark announced a $2 billion expansion, and GE Aerospace will invest $1 billion across 16 states. Thermo Fisher Scientific is putting $2 billion into expanding its U.S. footprint, and Merck & Co. has committed to $9 billion, including new biologics plants in Delaware.
Several investments also target sustainability and clean energy. AIP Management is backing solar developer Silicon Ranch with $500 million, and Schneider Electric will spend $700 million on U.S. energy infrastructure. AMG Critical Minerals is building a chrome facility in Pennsylvania, and Cyclic Materials is opening a rare earth recycling plant in Arizona.
More than 50 major companies have announced new or expanded operations, totaling well over $3 trillion in publicized private-sector investments since Trump’s second inauguration, reshaping the national economic and industrial landscape.
A flood of new corporate and foreign investment is transforming U.S. industry under Trump’s second term